Antiflammin-2, a nonapeptide of lipocortin-1, inhibits leukocyte chemotaxis but not arachidonic acid mobilization

European Journal of Pharmacology

Volumn 314, Issue 1-2, 1996, Pages 129-135

  Moreno, Juan J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

anti inflammatory drug; antiflammin; arachidonic acid; chemotaxis; inflammation; phospholipase A2

Indexed keywords

ANTIFLAMMIN 2; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM IONOPHORE; DEXAMETHASONE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLUCOCORTICOID; LIPOCORTIN 1 DERIVATIVE; NONAPEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE MIGRATION; MALE; MOUSE; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; FIBROBLASTS; HUMANS; MACROPHAGES, PERITONEAL; MALE; MICE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHAGOCYTES;

EID: 0030600512     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00521-3     Document Type: Article

References (42)

1. Barnes, P.J. and I.M. Adcock, 1993, Anti-inflammatory actions of steroids: molecular mechanisms, Trends Pharmacol. Sci. 14, 436.
2. 2, Biochem. Pharmacol. 44, 519.
3. Camussi, G., C. Tetta, F. Bussolino and C. Baglioni, 1990, Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions, J. Exp. Med. 171, 913.
4. Chan, C.C., M. Ni, L. Miele, E. Cordella-Miele, M. Ferrick, A.B. Mukherjee and R.B. Nussenblatt, 1991, Effects of antiflammins on endotoxin-induced uveitis in rats, Arch. Ophthalmol. 109, 278.
5. Cirino, G., S.H. Peers, R.J. Flower, J.L. Browning and R.B. Pepinsky, 1990, Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw oedema, Proc. Natl. Acad. Sci. USA 86, 3428.
6. 2 contains a Ca-dependent translocation domain with homology to PKC and GAP, Cell 65, 1043.
7. Cronstein, B.N., S.C. Kimmel, R.I. Levin, F. Martiniuk and G. Weissmann, 1992, A mechanism for the anti-inflammatory effects of corticosteroid: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1, Proc. Natl. Acad. Sci. USA 89, 9991.
8. 2, Biochem. Pharmacol. 38, 3645.
9. Di Rosa, M., R.J. Flower, F. Hirata, L. Parente and F. Ruso-Marie, 1984, Nomenclature announcement: antiphospholipase proteins, Prostagladins 28, 441.
10. Flower, R.J. and N.J. Rothwell, 1994, Lipocortin-1: cellular mechanisms and clinical relevance, Trends Pharmacol. Sci. 15, 71.
11. 2 in mouse macrophages and suppresses its activation, Biochem, J. 307, 499.
12. Goulding, N.J., J.L. Godolphin, P.R. Sharland, S.H. Peers, M. Sampson, P.J. Maddison and R.J. Flower, 1990, Antiinflammatory lipocortin 1 production by peripheral blood leukocytes in response to hydrocortisone, Lancet i, 1416.
13. Harris, J.G., R.J. Flower and M. Perretti, 1995, Alterations of neutrophil trafficking by a lipocortin-1 N-terminus peptide, Eur. J. Pharmacol. 279, 249.
14. 2 activities, Agents Actions 34, 77.
15. Lawrence, M.B. and T.A. Springer, 1991, Leukocytes roll on a selectin at physiological flow rates: distinction from and prerequisite for adhesion through integrins, Cell 65, 859.
16. Lasky, L.A., 1992, Selectins: interpreters of cell-specific carbohydrate information during inflammation, Science 258, 964.
17. Leyton, J., M.J. Manyak, A.B. Mukherjee, L. Miele, G. Mantile and S.R. Patierno, 1994, Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast conditioned medium, Cancer Res. 54, 3696.
18. 2 in coupled to hormonally regulated release of arachidonic acid, Proc. Natl. Acad. Sci. USA 92, 6147.
19. 2 is phosphorylated and activated by MAP kinase, Cell 72, 268.
20. Lloret, S. and J.J. Moreno, 1992, In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins, Biochem. Pharmacol. 44, 1437.
21. Lloret, S. and J.J. Moreno, 1994, Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation, Eur. J. Pharmacol. 264, 379.
22. Lloret, S., and J.J. Moreno, 1995, Effect of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application, Biochem. Pharmacol. 50, 347.
23. Lloret, S. and J.J. Moreno, 1996, Role of kinases and G-proteins on arachidonate release induced by zymosan in mouse peritoneal macrophages, Int. J. Biochem. Cell. Biol. 28, 465.
24. Lloret, S., J. Martínez and J.J. Moreno, 1995, Influence of calcium on arachidonic acid mobilization by murine resident peritoneal macrophages, Arch. Biochem. Biophys. 323, 251.
25. - generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages, J. Clin. Invest. 83, 1936.
26. 2 inhibitory and and-inflammatory activity, FEBS Lett. 262, 171.
27. 2(s): comparison of arachidonoyl-selective and-nonseleclive enzymes, FASEB J. 7, 339.
28. 2 inhibitors, Endocrinol. Rev. 8, 474.
29. Miele, L., E. Cordella-Miele, A. Facchiano and A.B. Mukherjee, 1988, Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I, Nature 335, 726.
30. Miele, L., E. Cordella-Miele, G. Mantile, A. Peri and A.B. Mukherjee, 1994, Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins, J. Endocrinol. Invest. 17, 679.
31. 2 activity. Implication for inflammatory disease, DNA Cell. Biol. 11, 233.
32. Perretti, M. and R.J. Flower, 1993, Modulation of interleukin-1 induced neutrophil migration by dexamethasone and lipocortin-1, J. Immunol. 150, 992.
33. Perretti, M., A. Ahluwalia, J.C. Harris, N.J. Goulding and R.J. Flower, 1993, Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse, J. Immunol. 151, 4306.
34. Perretti, M., S.K. Wheller, Q. Choudhury, J.D. Croxtall and R.J. Flower, 1995, Selective inhibition of neutrophil function by a peptide derived from lipocortin-1 N-terminus, Biochem. Pharmacol. 50, 1037.
35. Randall, G.W., J.C. Daniel Jr. and B.S. Chilton, 1991, Prolactin enhances uteroglobin gene expression by uteri of immature rabbits, J. Reprod. Fertil. 91, 249.
36. Rosen, S.D., S.I. Chi, D.D. True, M.S. Singer and T.A. Yednock, 1989, Intravenously injected sialidase inactivates attachment sites for lymphocytes on high endothelial venules, J. Immunol. 142, 1895.
37. Schleimer, R.P., H.N. Claman and A. Oponsky, 1989, in: Anti-inflammatory Steroid Action. Basic and Clinical Aspects (Academic Press, San Diego, CA).
38. 4, Biochem. Biophys. Res. Commun. 119, 884.
39. 2 inhibitory activity, FEBS Lett. 247, 293.
40. Vasanthakumar, G., R. Manjunath, A.B. Mukherjee, H. Warabi, and E. Schiffman, 1988, Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyte rejection, Biochem. Pharmacol. 37, 389.
41. Vostal, J.G., A.B. Mukherjee, L. Miele and N.R. Shulman, 1989, Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion, Biochem. Biophys. Res. Commun. 165, 27.
42. Venge, P, 1979, Kinetic studies of cell migration in a modified Boyden chamber: dependence on cell concentration and effects of the chymotrypsin-like cationic protein of human granulocytes, J. Immunol. 122, 1180.